Provided by Tiger Trade Technology Pte. Ltd.

Studio City International Holdings Ltd

3.30
+0.02000.61%
Volume:166.00
Turnover:538.37
Market Cap:636.90M
PE:-9.58
High:3.30
Open:3.30
Low:3.30
Close:3.28
52wk High:6.63
52wk Low:2.30
Shares:193.00M
Float Shares:17.01M
Volume Ratio:0.68
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3446
EPS(LYR):-0.5022
ROE:-11.40%
ROA:1.43%
PB:1.17
PE(LYR):-6.57

Loading ...

BRIEF-Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2025 Earnings

Reuters
·
Yesterday

Macau's Studio City Q4 revenue rises 4.8%, driven by mass market gaming

Reuters
·
Yesterday

Studio City posts FY2024 net loss of USD 96.73 million

Reuters
·
Yesterday

Studio City Q4 Revenue USD 160.3 Million

THOMSON REUTERS
·
Yesterday

High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD

GlobeNewswire
·
Yesterday

MSC Industrial Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
Feb 06

JPMorgan Downgrades MSC Industrial Direct to Neutral From Overweight, Adjusts Price Target to $95 From $96

MT Newswires Live
·
Feb 06

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

GlobeNewswire
·
Feb 05

Studio City International Holdings Ltd. to Release Unaudited Financial Results

Reuters
·
Feb 05

Press Release: MSC Income Fund Announces Appointment of New Director

Dow Jones
·
Feb 04

Mesoblast to Start Site Enrollment in Pivotal Trial for Cell Therapy Label Extension; Shares Fall 4%

MT Newswires Live
·
Jan 29

Ryoncil® Net Revenues Increase for the Quarter to US$30M

GlobeNewswire
·
Jan 29

Is MSC Industrial Direct (MSM) Fairly Priced After Recent Share Price Softness?

Simply Wall St.
·
Jan 28

MSC Income Fund price target raised to $16 from $15 at Citizens

TIPRANKS
·
Jan 27

Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment

GlobeNewswire
·
Jan 27

Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

GlobeNewswire
·
Jan 26

Royal Caribbean's RCL, MSC Cruises Get European Commission Approval For Joint Venture

MT Newswires Live
·
Jan 26

MSC Industrial shareholders back directors and governance measures

TIPRANKS
·
Jan 22

Cruise Lines Ramping Up Promotions in 1Q -- Market Talk

Dow Jones
·
Jan 21

Press Release: MSC Income Fund Announces Preliminary Estimate of Fourth Quarter 2025 Operating Results

Dow Jones
·
Jan 20